ArticleAlimentary pharmacology & therapeutics2008
Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin.
Article in Alimentary pharmacology & therapeutics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.BMC infectious diseases · 2017Trial
- Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.Journal of hepatology · 2011Trial
- New Therapies, Evidence, and Guidance in Hepatitis C Management: Expert Practices and Insights from an Educational Symposium at the AMCP 27th Annual Meeting Expo.Journal of managed care & specialty pharmacy · 2015Article
- Self-efficacy and adherence to antiviral treatment for chronic hepatitis C.Journal of clinical gastroenterology · 2015Article
- Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence.Journal of viral hepatitis · 2013Article
- Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?Journal of consulting and clinical psychology · 2013Review
- Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients.AIDS and behavior · 2013Article
- Adherence to chronic hepatitis C treatment regimen: first report from a referral center in iran.Hepatitis monthly · 2013Article
- Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study.Annals of internal medicine · 2011Article
- Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients.AIDS research and treatment · 2011Article
- Hepatitis C treatment eligibility and comorbid medical illness in methadone maintenance (MMT) and non-MMT patients: a case-control study.Journal of addictive diseases · 2010Article
- Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research.Alimentary pharmacology & therapeutics · 2009Review
- Adherence to hepatitis C virus therapy and early virologic outcomes.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2009Article
- Impact of hepatitis C treatment initiation on adherence to concomitant medications.The Journal of the Association of Nurses in AIDS Care : JANACArticle
- Self-reported treatment adherence in inflammatory bowel disease in Indian patients.Indian journal of gastroenterology : official journal of the Indian Society of GastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundPrior research on adherence to hepatitis C treatment has documented rates of dose reductions and early treatment discontinuation, but little is known about patients' dose-taking adherence.
aimsTo assess the prevalence of missed doses of pegylated interferon and ribavirin and examine the correlates of dose-taking adherence in clinic settings.
methodsOne hundred and eighty patients on treatment for hepatitis C (23% coinfected with HIV) completed a cross-sectional survey at the site of their hepatitis C care.
resultsSeven per cent of patients reported missing at least one injection of pegylated interferon in the last 4 weeks and 21% reported missing at least one dose of ribavirin in the last 7 days. Dose-taking adherence was not associated with HCV viral load.
conclusionsSelf-reported dose non-adherence to hepatitis C treatment occurs frequently. Further studies of dose non-adherence (assessed by method other than self-report) and its relationship to HCV virological outcome are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.